PhaseBio Pharmaceuticals Inc.

PHAS:NASDAQ

PhaseBio Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies to treat orphan diseases, with an initial focus on cardiopulmonary disorders.

streetwise book logo Streetwise Company Fact Sheet

2024/4/24 15:24:51

(PHAS:NASDAQ)